1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Financial Assessment of the Global Pharmaceutical and Biotechnology Industry 

Financial Management is the Key Strategy for Sustainability

This financial assessment study analyzes the financial ratios of public companies across the globe in the pharmaceutical and biotechnology industry. The research objectives are to rank companies based on their financial and risk management while also identifying key trends that can impact the performance of industry participants over the next year. Those analyzed include 718 publicly-listed pharmaceutical and 482 publicly-listed biotechnology companies across the globe. To assess the financial performance, ratios are divided into four categories: profitability, liquidity, activity (turnover), and solvency. Top performers in each industry are also highlighted.

The Key Issues/Challenges Faced by Industry Participants in the Pharmaceutical and Biotechnology Industry Include:

•The global economic slowdown
•Regulatory compliance
•Reducing profitability
•Increasing R&D costs
•Pricing pressures
•Counterfeit business

Financial Analysis of the Pharmaceutical and Biotechnology Industry

1. Margin Analysis
•The pharmaceutical industry has generally witnessed smaller margins due to increasing competition from generics, pricing pressures, and decreasing healthcare spending.
•In the biotechnology industry, companies within low revenue range and relatively new products have witnessed negative margins because of the heavy investment in R&D and SG&A (selling and general expenses).

2. Profitability Analysis
•Companies with a large portfolio of drugs have seen higher profitability in the pharmaceutical industry.
•The long timelines and accumulating expenditures incurred before a drug is commercialized is making the biotechnology industry less profitable in initial years, even resulting in negative margins for companies that are smaller in terms of revenue.

3. Turnover Analysis
•In both the pharmaceutical and biotechnology industries, companies with lower revenue had poor turnover ratios because of the huge investments made in assets and in the development of the product.

4. Cash Reserve Analysis
•In the pharmaceutical industry the smaller companies in terms of revenue are increasing their cash reserve as a percentage of their assets.
•In the biotechnology industry, both small and large companies in terms of revenue are increasing their cash reserve as a percentage of their assets.

5. R&D to Sales Ratio
•Both the pharmaceutical and biotechnology industries did not witness a great variation in the R&D to sales ratio in 2011 compared to the previous year. Though there was a general decline in the overall sales in both the pharmaceutical and biotechnology industries, the R&D expenses were not considerably reduced.

Who Will Benefit?

•Pharmaceutical & biotechnology companies
•Private equity
•Venture capital investors
•Fund managers
•Retail investors
•Sovereign wealth funds
•Hedge funds
•Insurance funds and other members of the investing community

Table Of Contents

Financial Assessment of the Global Pharmaceutical and Biotechnology Industry 
Table Of Contents

1. Executive Summary

2. Definition of Key Terms

3. Research Objective and Scope

4. Research Methodology

5. Key Issues/Challenges Faced by Industry Participants

6. Pharmaceutical Industry

7. Top Performers in the Pharmaceutical Industry

8. Biotechnology Industry

9. Top Performers in the Biotechnology Industry

10. The Frost and Sullivan Story

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
IMS World Review Executive™ 2016

IMS World Review Executive™ 2016

  • $ 6 860
  • Industry report
  • July 2016
  • by IMS Health

IMS World Review ExecutiveTM 2016 provides essential insights into worldwide sales of the pharmaceutical market, interlocking market trends and sales analysis from 2011 to 2015, including the breakdown ...

North America Syringes and Needles Market Outlook to 2021

North America Syringes and Needles Market Outlook to 2021

  • $ 5 995
  • Industry report
  • April 2016
  • by Global Data

North America Syringes and Needles Market Outlook to 2021 Summary GlobalData’s new report, "North America Syringes and Needles Market Outlook to 2021", provides key market data on the North America Syringes ...

Active Pharmaceutical Ingredient Market: (Manufacturing Process- Captive Manufacturing, Contract Manufacturing; API Type - Synthetic Chemical API, and Biological API; Drug Type - Branded Prescription Drugs, Generic Prescription Drugs and OTC Prescription

Active Pharmaceutical Ingredient Market: (Manufacturing Process- Captive Manufacturing, Contract Manufacturing; API Type - Synthetic Chemical API, and Biological API; Drug Type - Branded Prescription Drugs, Generic Prescription Drugs and OTC Prescription

  • $ 5 795
  • Industry report
  • March 2016
  • by Transparency Market Research

Active pharmaceutical ingredients (APIs) are bulk drug products that are used as raw materials for formulations. APIs of good quality are essential for the manufacture of effective and safe medicines. ...


Download Unlimited Documents from Trusted Public Sources

Cardiovascular Drug and Therapy Market in the US

  • July 2016
    39 pages
  • Cardiovascular ...  

    Therapy  

    Cardiovascular ...  

  • United States  

View report >

Pharmaceutical Industry in the UK

  • July 2016
    23 pages
  • Pharmaceutical  

  • United Kingdom  

    Europe  

    United States  

View report >

Anti-Infective Market in India

  • July 2016
    4 pages
  • Anti-Infective  

    Acne Treatment  

  • India  

    Asia  

View report >

Related Market Segments :

Pharmaceutical
Biotechnology

ref:plp2013

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.